Biochemistry researchers at the University of Illinois Urbana-Champaign are conducting trailblazing work on a group of conserved proteins that are directly related to abnormal cell proliferation and developmental and neurological disorders. In a new article published in Cell Reports, biochemistry...
Congratulations to the Tajkhorshid lab and collaborators who created a stunning research image recently highlighted by the National Institutes of Health.
In a study reported in the journal Chemical Science, researchers developed a new method to determine how antibiotics with specific chemical properties thread their way through tiny pores in the otherwise impenetrable cell envelopes of Gram-negative bacteria.
Thanks to the installation of a cryogenic electron microscope at the University of Illinois, researchers are exploring what was once hidden or difficult to study at the molecular level.
From helping bring a powerful, first-in-class HIV treatment to market to his most recent position as the CEO and co-owner of a preclinical contract research organization, Michael Recny (PhD, biochemistry, ’83) has paved a successful career path in the biotechnology industry, a field that was just...
Nicholas Wu, a professor of biochemistry at the University of Illinois Urbana-Champaign, has received a National Institutes of Health Director’s New Innovator Award, part of the Common Fund’s High-Risk, High-Reward Research program.
People infected with the original strain of the virus that causes COVID-19 early in the pandemic produced a consistent antibody response, making two main groups of antibodies to bind to the spike protein on the virus’s outer surface. However, those antibodies don’t bind well to newer variants, a...
A new approach to treating breast cancer kills 95-100% of cancer cells in mouse models of human estrogen-receptor-positive breast cancers and their metastases in bone, brain, liver and lungs. The newly developed drug, called ErSO, quickly shrinks even large tumors to undetectable levels.
